个人简介

王辰医师，呼吸与危重症医学、群医学及公共卫生专家，bat365正版唯一官网教授，bat365正版唯一官网学术咨询委员会学部委员，中国工程院院士，欧洲科学院、美国国家医学院外籍院士。国家呼吸医学中心主任，呼吸和共病全国重点实验室主任，Chinese Medical Journal总编辑。

主要研究内容

长期致力于呼吸与危重症医学、群医学及公共卫生领域的医疗、教学与研究工作。在慢性气道疾病、控制吸烟、呼吸衰竭与呼吸支持技术、肺栓塞与肺动脉高压、新发突发呼吸道传染病、共病及互作病、群医学理论等方面作出重要创新，改善医疗卫生实践。

代表性成果

1. Chen S#*, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, Wang Z, Li W, Geldsetzer P, Bärnighausen T, Bloom DE, Wang C*. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023 Apr 1;9(4):465-472. (IF=28.4, ESI)

2.   He Z#, Ren L#, Yang J#, Guo L#, Feng L#, Ma C, Wang X, Leng Z, Tong X, Zhou W, Wang G, Zhang T, Guo Y, Wu C, Wang Q, Liu M, Wang C, Jia M, Hu X, Wang Y, Zhang X, Hu R, Zhong J, Yang J, Dai J, Chen L, Zhou X, Wang J*, Yang W*, Wang C*. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021 Mar 20;397(10279):1075-1084. (IF=202.731, C100, ESI)

3.   Wang Y#, Zhang D#, Du G#, Du R#, Zhao J#, Jin Y#, Fu S#, Gao L#, Cheng Z#, Lu Q# , Hu Y#, Luo G#, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B*, Wang C*. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. (IF=79.323, C100, F1000, R, PIII, ESI)

4.   Wang C#*, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-473. (IF=79.323, C100)

5.   Huang K#, Yang T#, Xu J#, Yang L#, Zhao J#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Chen Y#, Sun T#, Shan G#, Lin Y#, Xu G#, Wu S#, Wang C, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y, Li W, Ding L, Wan C, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Wang Z, Chen Z, Bu X, Zhang H, Zhang X, An L, Zhang S, Zhu J, Cao Z, Zhan Q, Yang Y, Liang L, Tong X, Dai H, Cao B, Wu T, Chung KF, He J, Wang C*; China Pulmonary Health (CPH) Study Group. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019 Aug 3;394(10196):407-418. (IF=60.390, C100, ESI)

6.   Wang C#*, Xu J#, Yang L#, Xu Y#, Zhang X#, Bai C#, Kang J#, Ran P#, Shen H#, Wen F#, Huang K#, Yao W#, Sun T#, Shan G#, Yang T#, Lin Y#, Wu S#, Zhu J#, Wang R, Shi Z, Zhao J, Ye X, Song Y, Wang Q, Zhou Y, Ding L, Yang T, Chen Y, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Chen CS, Wang Z, Zhang H, Bu X, Zhang X, An L, Zhang S, Cao Z, Zhan Q, Yang Y, Cao B, Dai H, Liang L, He J*; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018 Apr 28;391(10131):1706-1717. (IF=59.102, C100, ESI)

7.   Zhan Q#*, Sun B, Liang L, Yan X, Zhang L, Yang J, Wang L, Ma Z, Shi L, Wei L, Li G, Yang L, Shi Z, Chen Y, Xu Q, Li W, Zhu X, Wang Z, Sun Y, Zhuo J, Liu Y, Li X, Wang C*. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med. 2012 Feb;40(2):455-60. (IF=6.124, C100, F1000)

8.   Wang C#*, Cao B*, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med. 2011 Aug 16;155(4):217-25. (IF=16.733, C100)

9.   Wang C#*, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010 Feb;137(2):254-62. (IF=6.519, C100, R)

10. Cao B#, Li XW#, Mao Y#, Wang J#, Lu HZ#, Chen YS#, Liang ZA#, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C#*; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009 Dec 24;361(26):2507-17. (IF=47.050, C100, R, ESI)